PROSPECTIVE NON-INTERVENTIONAL MULTI-CENTER STUDY EVALUATING BLEEDING INCIDENCE AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH HEMOPHILIA A WITH INHIBITORS AND NON-INHIBITORS TREATED WITH EMICIZUMAB AND OTHER HEMOPHILIA TREATMENTS IN A REAL-LIFE SETTING

drug protocol number
MO401001
drug sponsor
Roche
drug study
emicizumab
drug trial site
King Abdulaziz Medical City NG (Jeddah)
drug status
Ongoing
drug phase